The chemical makeup of cannabinoids varies, which affects how they react with the body. There are non-psychoactive cannabinoids called CBG and CBD. Background information about these two chemicals would explain some of the differences between them. It is clear from the current scientific literature that the research on these two chemicals is still in its nascent stages. Further studies are necessary to help us understand more about their individual qualities and effects.

One of the key differences here is the way that they occur in the plant itself. Cannabigerol (CBG) is considered to be a minor cannabinoid, as mature cannabis plants usually have very small amounts of it. The acidic form of it, known as cannabigerolic acid (CBGA), acts as a precursor compound for many major cannabinoids. On the other hand, cannabidiol (CBD) usually occurs in significantly larger amounts in specific hemp and cannabis strains.

In the comparison between CBG vs CBD, there is yet another factor to take into account, and that is the way in which each of them acts upon their biological receptors. It appears that CBG can affect cannabinoid receptors as well as other signaling systems, such as the alpha-2 adrenergic receptors and the serotonin system. CBD, on the other hand, acts upon several biological receptors as well, but in a somewhat different way. These differences in receptor activity help explain why CBG and CBD may produce different biological effects.

The scope of research into these two substances differs as well. CBD has been studied far more in-depth, both in clinical settings and in studies that explore its pharmacology, safety, and potential uses. CBG has started to receive increasing attention from researchers in recent years; however, there is significantly less human research done on it. Reviews of CBG have noted that many of the suggested uses still need further study.

It is important to look beyond just the name of the cannabinoid when selecting a product. The concentration, how it has been extracted, added substances, product formulation, and laboratory tests can all influence what exactly is in the product. There have even been studies that show some commercial cannabinoid products contain cannabinoid quantities different from those indicated on their labeling. Reviewing the certificate of analysis can give further information regarding the amount of cannabinoids and contaminants that might be present in the product.

As a concluding remark, one could say that CBG vs CBD considers the relationship between two similar but inherently different compounds. As of now, it is safer to state that both require further research to determine their potential benefits. With that being said, a person making a decision about such substances should also look into other aspects, including drug interactions and general safety instructions, since there are known cases of CBD’s negative effects on the liver.       

Tim Miller the author of this article. To know more about purchasing CBD oil please visit our website: www.cannariver.com